|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1650 Diagonal Road |
Address2 |
|
| City | ALEXANDRIA |
State | VA |
Zip Code | 22314 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1386-12
|
||||||||
|
6. House ID# 321810000
|
||||||||
| TYPE OF REPORT | 8. Year | 2022 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Christopher Stewart |
Date | 10/20/2022 3:18:39 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
September 30, 2022, coalition letter to Representatives Ami Bera and Larry Bucshon thanking them for introducing H.R. 8800, the Supporting Medicare Providers Act of 2022 (legislation to avert some of the scheduled cuts to Medicare reimbursement rates for physicians).
September 29, 2022, Alliance of Specialty Medicine letter to Representatives Ami Bera and Larry Bucshon thanking them for introducing H.R. 8800, the Supporting Medicare Providers Act of 2022 (legislation to avert some of the scheduled cuts to Medicare reimbursement rates for physicians).
September 28, 2022, letter to FDA Commissioner Califf expressing concern regarding the ongoing national shortage of tracheostomy tubes for pediatric and adult patients.
September 22, 2022, coalition letter to Speaker Pelosi, Leader McCarthy, Leader Schumer, and Leader McConnell warning about the impact of scheduled cuts to Medicare reimbursement for physicians and asking Congress to take action on overall reform for Medicare payment.
September 14, 2022, coalition letter to Representatives Ami Bera and Larry Bucshon thanking them for introducing H.R. 8800, the Supporting Medicare Providers Act of 2022 (legislation to avert some of the scheduled cuts to Medicare reimbursement rates for physicians).
September 6, 2022, coalition letter to CMS Administrator Brooks-LaSure expressing concerns with the Medicare Physician Fee Schedule global surgical package.
August 1, 2022, Alliance of Specialty Medicine coalition letter to HHS Assistant Secretary Levine responding to the "Request for Information (RFI): HHS Initiative To Strengthen Primary Health Care."
July 28, 2022, Alliance of Specialty Medicine letter to Representatives Michael Burgess and Vicente Gonzalez thanking them for introducing H.R. 7995, the GOLD CARD Act (legislation to reform the prior authorization process under the Medicare Advantage program).
July 27, 2022, coalition letter to congressional leadership for the Senate Finance, House Ways and Means, and House Energy and Commerce committees regarding concerns over scheduled cuts to Medicare reimbursement rates for physicians.
July 18, 2022, coalition letter to Senate Majority Leader Schumer and Speaker Pelosi urging investment in the healthcare workforce and robust funding for Graduate Medical Education (GME).
July 18, 2022, letter to Sandra Battiste, MPH, of the Health Resources & Services Administration, responding to the Request for Information: Early Hearing Detection and Intervention Program.
July 7, 2022, Physician Clinical Registry Coalition letter to Michelle Schreiber, MD, Deputy Director of the Centers for Clinical Standards and Quality at the Centers for Medicare & Medicaid Services (CMS), expressing concerns with the measure set review (MSR) process.
July 6, 2022, letter to Representatives Michael Burgess and Vicente Gonzalez thanking them for introducing H.R. 7995, the GOLD CARD Act (legislation to reform the prior authorization process under the Medicare Advantage program).
Issues pertaining to the scope of practice legislation, related to H.R. 1587/S. 1731 and H.R. 6087, and in general.
Issues pertaining to prior authorization, related to H.R. 3173/H.R. 8487/S. 3018 and H.R. 7995, and in general.
Issues pertaining to the Early Hearing Detection and Intervention Program, related to H.R. 5561/S. 4052, and in general.
Issues pertaining to Medicare physician reimbursement, related to H.R. 8800, and in general.
Issues related to hearing healthcare, in general.
Issues pertaining to health information technology and electronic health records, in general.
Issues pertaining to Language Equality and Acquisition for Deaf Kids (LEAD-K) and parent choice, in general.
Issues pertaining to Graduate Medical Education, in general.
Issues pertaining to COVID-19, in general.
Issues pertaining to healthcare liability reform, in general.
Issues pertaining to healthcare practice and the Federal Supremacy Clause at the Department of Veterans Affairs, in general.
Issues related to the potential expansion of Medicare to cover hearing health benefits in potential reconciliation legislation.
Issues pertaining to the "Magnet Injury Prevention Act," H.R. 8199/S. 4479.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Federal Trade Commission (FTC), Centers For Medicare and Medicaid Services (CMS), Health Resources & Services Administration (HRSA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Stewart |
|
|
|
Maura |
Farrell |
|
|
|
Thomas |
Radder |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
September 30, 2022, coalition letter to Representatives Ami Bera and Larry Bucshon thanking them for introducing H.R. 8800, the Supporting Medicare Providers Act of 2022 (legislation to avert some of the scheduled cuts to Medicare reimbursement rates for physicians).
September 29, 2022, Alliance of Specialty Medicine letter to Representatives Ami Bera and Larry Bucshon thanking them for introducing H.R. 8800, the Supporting Medicare Providers Act of 2022 (legislation to avert some of the scheduled cuts to Medicare reimbursement rates for physicians).
September 22, 2022, coalition letter to Speaker Pelosi, Leader McCarthy, Leader Schumer, and Leader McConnell warning about the impact of scheduled cuts to Medicare reimbursement for physicians and asking Congress to take action on overall reform for Medicare payment.
September 14, 2022, coalition letter to Representatives Ami Bera and Larry Bucshon thanking them for introducing H.R. 8800, the Supporting Medicare Providers Act of 2022 (legislation to avert some of the scheduled cuts to Medicare reimbursement rates for physicians).
September 6, 2022, coalition letter to CMS Administrator Brooks-LaSure expressing concerns with the Medicare Physician Fee Schedule global surgical package.
July 28, 2022, Alliance of Specialty Medicine letter to Representatives Michael Burgess and Vicente Gonzalez thanking them for introducing H.R. 7995, the GOLD CARD Act (legislation to reform the prior authorization process under the Medicare Advantage program).
July 27, 2022, coalition letter to congressional leadership for the Senate Finance, House Ways and Means, and House Energy and Commerce committees regarding concerns over scheduled cuts to Medicare reimbursement rates for physicians.
July 18, 2022, coalition letter to Senate Majority Leader Schumer and Speaker Pelosi urging investment in the healthcare workforce and robust funding for Graduate Medical Education (GME).
July 7, 2022, Physician Clinical Registry Coalition letter to Michelle Schreiber, MD, Deputy Director of the Centers for Clinical Standards and Quality at the Centers for Medicare & Medicaid Services (CMS), expressing concerns with the measure set review (MSR) process.
July 6, 2022, letter to Representatives Michael Burgess and Vicente Gonzalez thanking them for introducing H.R. 7995, the GOLD CARD Act (legislation to reform the prior authorization process under the Medicare Advantage program).
Issues pertaining to the scope of practice legislation, related to H.R. 1587/S. 1731, and in general.
Issues pertaining to prior authorization, related to H.R. 3173/H.R. 8487/S. 3018 and H.R. 7995, and in general.
Issues pertaining to the Early Hearing Detection and Intervention Program, related to H.R. 5561/S. 4052, and in general.
Issues pertaining to Medicare physician reimbursement, related to H.R. 8800, and in general.
Issues related to hearing healthcare, in general.
Issues pertaining to health information technology and electronic health records, in general.
Issues pertaining to COVID-19, in general.
Issues related to the potential expansion of Medicare to cover hearing health benefits in potential reconciliation legislation.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Stewart |
|
|
|
Maura |
Farrell |
|
|
|
Thomas |
Radder |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Issues pertaining to tobacco control, in general.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Maura |
Farrell |
|
|
|
Thomas |
Radder |
|
|
|
Christopher |
Stewart |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Issues pertaining to healthcare practice and the Federal Supremacy Clause at the Department of Veterans Affairs, in general.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Stewart |
|
|
|
Maura |
Farrell |
|
|
|
Thomas |
Radder |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |